Our Team
PD Dr. Andreas Lutterotti, MD
He is a neurologist by training with core expertise in early treatment development in multiple sclerosis.
Currently he is Lead Physician and Head of the Neuroimmunological Outpatient Clinic at BMG and Chief Medical Officer at Cellerys.
Prof. Dr. Roland Martin, MD
He has an internationally recognised track record in the field of multiple sclerosis including the development of innovative treatments.
Currently he pursues research at the University of Zürich and Karolinska Institute (Stockholm) and he is Chief Scientific Officer at Cellerys.
Health Economics Lead
Mikolaj Czaplinski
MA (Oxford) and MSc (LSE), joined Bellevue Medical Group in 2022 to lead health economics.
Former investment analyst with experience in digital health.
Senior Scientist
Mireia Sospedra Ramos, PhD
Immunologist with over 20 years of research experience across Spain, France, the U.S., Germany, and Switzerland.
She has a strong background in human immunology and multiple sclerosis, over 80 scientific publications, and holds master’s degrees in scientific communication as well as nutrition and food. She is Senior Principal Scientist at Cellerys.
Clinical Trials Operations Manager
Jeremia Held, PhD
PhD in neurorehabilitation with 10+ years in research and clinical trial management, 50+ scientific publications.
Clinical Trials Operations Manager at Bellevue Medical Group since 2024.
Managing Director
Magdalena Rijk
Czaplinski, CFA
MSc in Finance and Banking, MSc in International Management, CFA. 12 years in corporate finance at Novo Nordisk, 6 years in global strategic HR at Swiss Re.
Managing Director of Bellevue Medical Group since 2018, skilled in building and managing healthcare SMEs